VersaPay’s stock could soon return to last year’s highs: PI

Sales growth looks to be picking up for VersaPay (VersaPay Stock Quote, Chart TSXV:VPY), according to PI Financial analyst David Kwan, who last Thursday wrote an update in response to the company’s latest earnings report, saying the stock may be returning to last year’s highs.

Cloud-based invoice and payment company VersaPay announced its Q4 and full year 2018 financials last Tuesday, reporting revenues that were up 37 per cent year-over-year and 28 per cent quarter-over-quarter to $1.5 million and Adjusted EBITDA of negative $1.2 million.

In addition to the record revenue, the company’s annual recurring revenue backlog increased by 46 per cent quarter-over-quarter to a record $1.8 million.

Kwan says that the quarter’s top line beat his and the consensus estimate of $1.3 million, while the Adjusted EBITDA loss was in-line with expectations. He says VersaPay should get more sales from its ARC platform later this year through its customer RBC, which is poised to be a major revenue growth driver for VPY in coming years, says Kwan, who also notes that the company expects to announce details of a partnership with a major global fintech company later this quarter.

Kwan takes the quarterly results as a positive.

“VPY ended the year on a high, with a sharp pick up in key revenue metrics that suggest sales growth is poised to re-accelerate, which when combined with some more positive news flow (including significant partnerships), could help the stock return to the highs seen last year,” he said.

The analyst is leaving his fiscal 2019 revenue forecast unchanged at $9.6 million but is lowering his Adjusted EBITDA estimate to negative $6.9 million from negative $4.6 million. He is introducing fiscal 2020 estimates of $17.9 million in revenue and negative $1.0 million in Adjusted EBITDA.

Kwan is reiterating his “Buy” rating and $2.30 target price, which represents a projected 12-month return on investment of 58.6 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vpy
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago